Opko Health Inc (OPK)

[Recognizer]

Financial analysts are motley FOOLS
I m not sure where many so called financial analysts come from but they wear their title loosely. I do not view many on wall street to be competent or astute when it comes to analyzing and then reporting their findings. On OPK many analysts cited the earnings report as a mixed bag claiming their losses were wider than expected. Well losses in a company that is highly noted as an medical R&D house - spends money on investments in their future vs losses that come from poor execution on a product line. To speak of losses in R&D as you would with companies making a product is beyond foolish - it is well stupid. OPK will easily spend millions testing new products in lengthy and complicated trials or R&D phase but their track record of producing winners is exceptional. What is likely occurring is manipulating a stock rather than honest journalism and scientific investigating. it is sad that this is the best our financial industry has to offer. Perhaps it is only fitting that many in financial institutions today were failures at one point while taking their academic journey. Motley Fools seems to support my claim on tis one